​

Portage Biotech (PRTG) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

PRTG Stock Forecast

Portage Biotech (PRTG) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $4.88, with a high of $5.25 and a low of $4.50. This represents a -22.66% decline from the last price of $6.31.

- $1 $2 $3 $4 $5 $6 $7 High: $5.25 Avg: $4.88 Low: $4.5 Last Closed Price: $6.31

PRTG Stock Rating

Portage Biotech stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

PRTG Price Target Upside V Benchmarks

TypeNameUpside
StockPortage Biotech-22.66%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$6.31$6.31$6.31
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 24--1--1
Oct, 24--1--1
Sep, 24--1--1
Aug, 24--1--1
Jul, 24--1--1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 01, 2022H.C. Wainwright$5.25$1.47257.14%-16.80%
Nov 30, 2022Oppenheimer$4.50$1.49202.01%-28.68%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 30, 2022OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

$-55 $-46 $-37 $-28 $-19 $-10 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28
Mar 24Mar 25Mar 26Mar 27Mar 28
Reported-----
Avg Forecast$-54.40$-13.00$-10.40$-29.60$-21.60
High Forecast$-54.40$-13.00$-10.40$-29.60$-21.60
Low Forecast$-54.40$-13.00$-10.40$-29.60$-21.60
Surprise %-----

Revenue Forecast

Mar 24 Mar 25 Mar 26 Mar 27 Mar 28
Mar 24Mar 25Mar 26Mar 27Mar 28
Reported-----
Avg Forecast----$2.50M
High Forecast----$2.50M
Low Forecast----$2.50M
Surprise %-----

Net Income Forecast

$-1B $-960M $-770M $-580M $-390M $-200M Mar 24 Mar 25 Mar 26 Mar 27 Mar 28
Mar 24Mar 25Mar 26Mar 27Mar 28
Reported-----
Avg Forecast$-1.11B$-264.43M$-211.54M$-602.08M$-439.35M
High Forecast$-1.11B$-264.43M$-211.54M$-602.08M$-439.35M
Low Forecast$-1.11B$-264.43M$-211.54M$-602.08M$-439.35M
Surprise %-----

PRTG Forecast FAQ

Is Portage Biotech stock a buy?

Portage Biotech stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Portage Biotech is a favorable investment for most analysts.

What is Portage Biotech's price target?

Portage Biotech's price target, set by 4 Wall Street analysts, averages $4.88 over the next 12 months. The price target range spans from $4.5 at the low end to $5.25 at the high end, suggesting a potential -22.66% change from the previous closing price of $6.31.

How does Portage Biotech stock forecast compare to its benchmarks?

Portage Biotech's stock forecast shows a -22.66% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Portage Biotech over the past three months?

  • November 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Portage Biotech’s EPS forecast?

Portage Biotech's average annual EPS forecast for its fiscal year ending in March 2024 is $-54.4, marking a 0% decrease from the reported - in 2023. Estimates for the following years are $-13 in 2025, $-10.4 in 2026, $-29.6 in 2027, and $-21.6 in 2028.

What is Portage Biotech’s revenue forecast?

Portage Biotech's average annual revenue forecast for its fiscal year ending in March 2024 is $0, reflecting a 0% decrease from the reported - in 2023. The forecast for 2025 is $0, followed by $0 for 2026, $0 for 2027, and $2.5M for 2028.

What is Portage Biotech’s net income forecast?

Portage Biotech's net income forecast for the fiscal year ending in March 2024 stands at $-1.107B, representing a 0% decrease from the reported - in 2023. Projections indicate $-264M in 2025, $-212M in 2026, $-602M in 2027, and $-439M in 2028.